We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+9.37%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$29.8B
AUM Growth
+$2.61B
Cap. Flow
+$204M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.49%
Holding
319
New
30
Increased
92
Reduced
86
Closed
4

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$62.9M
2
OGN icon
Organon & Co
OGN
+$57.9M
3
MAR icon
Marriott International
MAR
+$50.4M
4
MSFT icon
Microsoft
MSFT
+$48.5M
5
NOW icon
ServiceNow
NOW
+$38.6M

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$75.9M
2
ABBV icon
AbbVie
ABBV
+$59.9M
3
AAPL icon
Apple
AAPL
+$28.9M
4
MO icon
Altria Group
MO
+$19.2M
5
MRK icon
Merck
MRK
+$13M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 20.63%
3 Consumer Staples 18.28%
4 Communication Services 11.3%
5 Healthcare 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
101
Alphabet (Google) Class A
GOOGL
$4.36T
$8.56M 0.03%
70,080
+10,320
+17% +$1.21M
CNS icon
102
Cohen & Steers
CNS
$4.23B
$8.21M 0.03%
100,000
EOG icon
103
EOG Resources
EOG
$79.2B
$8.09M 0.03%
96,941
+269
+0.3% +$21.3K
GILD icon
104
Gilead Sciences
GILD
$162B
$7.99M 0.03%
115,996
+25,866
+29% +$1.73M
MDT icon
105
Medtronic
MDT
$109B
$7.22M 0.02%
58,207
-1,153
-2% -$145K
LLY icon
106
Eli Lilly
LLY
$1.02T
$6.79M 0.02%
29,577
+1,894
+7% +$380K
MMM icon
107
3M
MMM
$90.9B
$6.61M 0.02%
39,771
+3,371
+9% +$563K
VZ icon
108
Verizon
VZ
$195B
$6.47M 0.02%
115,469
+31,468
+37% +$1.81M
SBR
109
Sabine Royalty Trust
SBR
$1.06B
$6.1M 0.02%
151,249
LMT icon
110
Lockheed Martin
LMT
$134B
$5.87M 0.02%
15,520
+6,664
+75% +$2.56M
PLD icon
111
Prologis
PLD
$135B
$5.78M 0.02%
48,390
+1,110
+2% +$130K
NEE icon
112
NextEra Energy
NEE
$181B
$5.67M 0.02%
77,438
-1,058
-1% -$79.4K
LEG icon
113
Leggett & Platt
LEG
$1.34B
$5.43M 0.02%
104,851
+24,851
+31% +$1.29M
FMX icon
114
Fomento Económico Mexicano
FMX
$43.6B
$5.29M 0.02%
62,635
-1,200
-2% -$98.3K
CAT icon
115
Caterpillar
CAT
$375B
$5.27M 0.02%
24,230
+2,998
+14% +$692K
WFC icon
116
Wells Fargo
WFC
$261B
$5.25M 0.02%
115,979
COST icon
117
Costco
COST
$422B
$4.97M 0.02%
12,560
BSM icon
118
Black Stone Minerals
BSM
$3.18B
$4.96M 0.02%
461,748
DUK icon
119
Duke Energy
DUK
$97.8B
$4.92M 0.02%
49,819
+15,709
+46% +$1.58M
HON icon
120
Honeywell
HON
$77B
$4.79M 0.02%
23,196
+8,214
+55% +$1.74M
IBM icon
121
IBM
IBM
$211B
$4.76M 0.02%
33,951
+13,604
+67% +$1.86M
FOXA icon
122
Fox Class A
FOXA
$24.5B
$4.75M 0.02%
127,857
-1,143
-0.9% -$42.9K
SJM icon
123
J.M. Smucker
SJM
$12.7B
$4.75M 0.02%
36,624
AMGN icon
124
Amgen
AMGN
$208B
$4.58M 0.02%
18,795
-1,334
-7% -$328K
RETA
125
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4.26M 0.01%
30,129

Similar funds

Fayez Sarofim & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Fayez Sarofim & Co held 319 positions worth $29.8B, up 9.6% from $27.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q2 2021 filing shows 30 new, 92 increased, 86 reduced and 4 closed positions. Its largest new stake was Organon & Co: 1,758,918 shares worth $53.2M. The largest sale was Chubb, an estimated $75.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q2 2021 buy was Organon & Co: 1,758,918 shares worth $53.2M.
  • Fayez Sarofim & Co added most to Procter & Gamble in Q2 2021, an estimated $62.9M increase.
  • Fayez Sarofim & Co's biggest Q2 2021 reduction was Chubb, cutting an estimated $75.9M.
  • Fayez Sarofim & Co fully exited US Bancorp in Q2 2021, selling an estimated $359K.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $29.8B portfolio in Q2 2021.
  • Fayez Sarofim & Co opened 30 new positions and closed 4 in Q2 2021.
  • Fayez Sarofim & Co's portfolio value rose 9.6% quarter-over-quarter to $29.8B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2021, filed 13 Aug 2021.